PVI
ALPN

Pura Vida Investments’s Alpine Immune Sciences Inc ALPN Stock Holding History

Pura Vida Investments’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-30,924
Closed -$227K – 182
2022
Q4 		$227K Buy
+30,924
New +$198K 0.01% 179
2021
Q2 		– Sell
-131,981
Closed -$1.4M – 283
2021
Q1 		$1.4M Sell
131,981
-5,127
-4% -$63.9K 0.04% 182
2020
Q4 		$1.73M Buy
+137,108
New +$1.35M 0.06% 149

Other funds holding ALPN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Pura Vida Investments's ALPN Position: Q1 2023 in Review

Pura Vida Investments sold out of Alpine Immune Sciences Inc (ALPN) in Q1 2023, closing a stake of 30,924 shares — an estimated $227K sold.

Pura Vida Investments first reported a position in ALPN in Q4 2020 and held it in 3 quarters. The position peaked at $1.73M in Q4 2020. 60 funds tracked by Wall St. Rank hold ALPN as of Q1 2023.

  • Pura Vida Investments reported no remaining Alpine Immune Sciences Inc position as of Q1 2023 after selling out during the quarter.
  • Pura Vida Investments sold 30,924 Alpine Immune Sciences Inc shares in Q1 2023, an estimated $227K.
  • Pura Vida Investments first reported a position in Alpine Immune Sciences Inc in Q4 2020 and held it in 3 quarters.
  • Pura Vida Investments's Alpine Immune Sciences Inc position peaked at $1.73M in Q4 2020.
  • 60 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q1 2023.

Based on Pura Vida Investments's 13F filing for Q1 2023, filed 15 May 2023.